Delta 9 disposable vapes have become one of the most convenient ways for adults to enjoy hemp-derived cannabinoids. Their compact design, ease of use, and fast-acting effects make them a popular choice among both new and experienced users. Unlike refillable vape devices, disposable vapes come pre-filled and ready to use, eliminating the need for charging, refilling, or replacing cartridges in many models.

Yes, cops should do mushrooms. So should firefighters, paramedics, prison guards, and — while we’re at it — the prisoners themselves. Not recreationally on shift, obviously. Under medical supervision, as part of a deliberate effort to treat the psychological wreckage that these jobs, and this system, leave behind. Let me explain why I think that’s not a punchline, but a policy position with real evidence behind it

Fox News opinion ran a piece recently from Scott Chipman, vice president of Americans Against Legalizing Marijuana, arguing that legal cannabis "didn't kill the black market, it created a marketing department for it."

Corporate valuation increased in 21 of the 38 states studied following medical marijuana legalization. Gross profit per employee and gross sales per employee each rose by more than $8,000. Patent output climbed 10.4% across those states, and the economic value of those patents — not just the count, but how much they were actually worth — rose 22%, as states became better at both retaining their existing inventors and pulling in new ones from states that hadn't legalized.

By gently heating your plant matter instead of setting it on fire, a vaporizer extracts far more goodness out of every single milligram. You get more sessions per quarter, spend less money at the dispensary, reduce daily environmental waste, and even get usable leftover material for homemade treats.

For the past five years, Texas has lived in a strange legal limbo. The 2018 Farm Bill legalized hemp at the federal level, defining it as cannabis with 0.3% or less delta-9 THC by dry weight. Texas, like most states, wrote that definition into its own hemp program. Entrepreneurs took the opening and ran with it, building a multi-billion-dollar industry of delta-8, delta-10, THCA flower, and other hemp-derived cannabinoids that got people high without technically being "marijuana." The Texas Department of State Health Services tried to shut this down by rule in 2021, reclassifying those cannabinoids as Schedule I controlled substances. A court blocked it with an injunction. For five years, the shops stayed open.

According to the latest quarterly NuggMD/Marijuana Moment tracking poll, only 48 percent of marijuana consumers now approve or strongly approve of the Trump administration’s cannabis actions. That’s down from 73 percent last quarter. Thirteen percent disapprove, and a striking 40 percent have simply checked out into “no opinion” territory. When four in ten of your most engaged constituency shrugs at you, that’s not apathy. That’s disillusionment wearing apathy’s coat.

Senate Democrats just refiled a bill that does the thing rescheduling was never designed to do: end federal cannabis prohibition outright. Cory Booker, Chuck Schumer, and Ron Wyden reintroduced the Cannabis Administration and Opportunity Act on July 16, and while it will almost certainly die in a Republican-controlled House the same way its last two versions did, it's worth sitting with why this bill matters more than the rescheduling process everyone in Washington is currently fixated on.

I'm not a doctor and I'm not diagnosing Sharon Stone. I'm telling you that the simplest explanation on the table — a woman with a serious neurological history had a rough physiological month after stacking two withdrawals back to back — doesn't need a villain. It got one anyway, because "modern weed is poison" is a better headline than "recovery is complicated."

Cannabis cafe culture and consumption lounges are incredibly important for the industry. There are many reasons why. For one, it directly solves a problem relating to access. Lounges already close the gap and take consumption outside residences, public parks, hotel bathrooms, and cars into licensed spaces that are manned by professionals. It also helps that these spaces are properly ventilated.

For all the noise around CBD in the United States, from Farm Bill loopholes to state-by-state confusion, the conversation almost never lands on the thing that actually affects the person buying a bottle: can you trust what is in it? Across the Atlantic, that question has been answered better, and not through louder marketing. It happened through a culture that treats testing and transparency as the baseline rather than a bonus.

Americans have gotten comfortable. Forty-plus states have some form of legal cannabis on the books, dispensaries have started to look like Apple Stores, and an entire generation of consumers has grown up assuming weed is basically fine everywhere now. It is not fine everywhere now. It is barely fine in most of the country, and the second you cross an international border, or even a state line into the wrong state, you are stepping out of a bubble that the rest of the world never agreed to build with you.

wyOver the past few years, however, there has been a significant decline in opioid-related fatalities. There have been important tools that contributed to this: increased naloxone distribution, improved surveillance, and fentanyl test strips. But we aren’t giving enough credit to how cannabis legalization has also played a critical role in reducing opioid-related deaths.

A recent survey of nearly 1,000 employers, reported by the Wall Street Journal and covered by NORML, found that about half no longer screen job applicants for cannabis before hiring. The reason employers gave most often wasn’t a philosophical awakening about bodily autonomy — it was simpler and more honest than that: they wanted a bigger applicant pool. Turns out that when you disqualify a huge swath of otherwise-qualified candidates over something with zero bearing on job performance, you shrink your own hiring options. Who knew.

Here’s the ground truth, state by state, as of July 2026, drawn from NORML’s state law tracker and Forbes’ 2026 legal-status roundup.

The Court ruled that the federal government cannot restrict gun ownership based solely on the fact that someone uses marijuana, finding that certain prosecutions under 18 U.S.C. § 922(g)(3) intrude on the Second Amendment’s right to “keep and bear arms.”

Start with who's actually raising kids in America today. The generation currently in the thick of parenting — late twenties through mid-forties — came of age through the internet, through the tail end of the D.A.R.E. era collapsing under its own credibility, through state after state legalizing while the sky stubbornly refused to fall. This is the straddle generation: Gen X and millennial, the ones who watched prohibition-era messaging get quietly retired in real time.

Researchers looked specifically at participants aged 40 to 70 (average age 54.5) and asked a question nobody had really nailed down: what does lifetime cannabis use actually do to the brain once you're past the age everyone loves to study — the twentysomething brain that's still finishing construction?

I'm an old school stoner. I was here before legalization was a punchline on late-night television, before dispensaries had loyalty programs, before anybody put a leaf on a billboard. I remember when this plant could cost you your kids, your job, your freedom, your life, and people smoked it anyway, because some things are worth the risk. So when I hear rumblings about reversing course, about reclassifying, recriminalizing, rebuilding the machinery of the drug war one quiet regulation at a time, I don't feel panic. I feel something closer to recognition. We've been here before. We know how this goes.

Let's start with the headline nobody in Washington wants to print: marijuana is still illegal. Not "illegal-ish." Not "illegal with an asterisk." Federally, under the Controlled Substances Act, cannabis remains a Schedule I narcotic, officially grouped with heroin and LSD, officially declared to have no accepted medical use. That fact hasn't moved an inch this year, despite a summer's worth of DEA hearings, legal filings, and breathless coverage suggesting otherwise.

A rolling reserve on a high-risk account holds 5% to 10% of every sale for as long as 180 days. For a CBD merchant, that money is real revenue kept out of reach, and a single processor decision can turn a slow hold into a full freeze overnight. The freeze is rarely random. It follows a mistake the merchant made weeks earlier and never saw as dangerous.

For years, the cannabis world has treated "the entourage effect" like settled science, a comforting shorthand for why whole-plant weed hits different than an isolated THC pill. Terpenes and cannabinoids work together, the story goes, adding up to more than the sum of their parts. It's a nice idea. It's also, according to a new pre-proof study headed for the journal Biochemical Pharmacology, an oversimplification that's been doing a lot of unearned work in how we talk about cannabis.

The Washington State Department of Health just published a health advisory for FIFA World Cup visitors. It includes the standard warnings: start low, go slow, don’t drive, don’t mix with alcohol, edibles can take three hours and last up to 24. It is responsible, accurate, and completely inadequate for anyone who has never encountered what’s on dispensary shelves here.

According to the National Survey on Drug Use and Health (NSDUH), past-year cannabis use among Americans 12 and older climbed from 11.0% in 2002 to 22.3% in 2024 — a 103% increase. Over roughly the same period, past-month alcohol use dropped from 51% to 46.6%, a 9% decline. These aren’t rounding errors. They represent one of the most significant substance-use shifts in modern American history, and it’s happening largely without a formal policy directing it. No public health campaign told people to put down the beer and pick up the joint. They did it on their own.

These days, cannabis has successfully permeated almost every field of medicine. This reflects the scientific interest that the plant has attracted over the past 20 years or so. It’s crazy to think that what was once a strictly prohibited body of research is now one of the quickest-growing fields in science. In fact, major universities, health centers, hospitals, and even governments around the world clamor to study weed’s therapeutic benefits.

I know. You’re tired of hearing about AI. Half your feed is either someone gushing about their AI-generated side hustle or someone else losing their mind because a machine wrote a poem. The discourse has collapsed into two camps: the breathlessly optimistic and the chronically offended, and somehow neither side is saying anything useful about what’s actually happening.

Around 25, the ECS completes its development. The scaffolding comes down. Endocannabinoid production drops from the elevated levels of adolescence to adult maintenance levels — a significant reduction that shifts the entire baseline of the system.

The DEA announced the participants for its upcoming cannabis rescheduling hearing. June 2026. Momentous occasion, right? The machinery of federal government finally grinding toward something resembling justice for a plant that’s been federally prohibited for over fifty years.

Open source systems optimize for the function they actually perform, because anyone can see the code, find the bugs, propose improvements, and fork the project if the maintainers go sideways. The Linux kernel is more reliable than any proprietary operating system not because the people who built it were smarter, but because the model for building it is fundamentally superior.

Cathy O'Brien is a controversial figure. A survivor of what she claims was a CIA-connected mind control program called MK-Ultra, her testimony occupies the uncomfortable intersection between documented government abuse of citizens and conspiracy theory territory that most mainstream commentators prefer to dismiss wholesale.

Industrial hemp is a variety of Cannabis sativa L. cultivated specifically for non-psychoactive applications: fibre, seed, oil, and biomass. It contains less than 0.2% THC, the compound responsible for cannabis's psychoactive effects, which is the legal threshold the European Union applies to licensed cultivation. The crop is genetically and functionally distinct from marijuana in all commercially relevant ways.

Robinhood is a popular US-based investment app that allows everyday individuals to buy and sell stocks straight from their smartphones or computers. It offers commission-free trading not just of stocks but also ETFs, cryptocurrencies, options, and retirement accounts.

Start reading studies like a journalist rather than a supplicant. Find out who funded them, what products they actually tested, whether the blinding held, what the outcome measures were designed for, and when they were published relative to regulatory decisions they conveniently support. Most people who read the Wilson review headline stopped at the abstract. The abstract is where the playbook wants you to stop.

A greenhouse gives you better light and lower energy overhead. Add a properly designed hydroponic system, and you close the remaining performance gap between greenhouse and indoor yields. Hydroponics in a greenhouse context operates by delivering nutrient-rich water directly to the root zone, bypassing the inefficiencies of soil entirely.

Tyler Cowen published a piece in The Free Press recently asking whether we should recriminalize marijuana. He landed, sensibly, against it. The comment section of his blog filled up with the usual range: suburban homeowners insisting legalization ruined New York City, economists arguing about social norms, at least one guy who seems to think the solution to homelessness is making pot illegal again. The full spectrum of American cannabis discourse, in other words: heated, occasionally intelligent, and mostly beside the actual point.

The bill, passed with bipartisan support, would allow terminally ill patients to use medical marijuana for pain management even while hospitalized. That's the story. That's the bill. And somewhere in the machinery of American governance, enough people had enough reservations about this that it required an act of legislation to make it possible.

A recent study conducted by investigators at Yale University and the University of Oxford in the United Kingdom analyzed cognitive performance among lifetime weed users, then compared them to non-users in various aspects. They tested for memory, problem solving, and intelligence.

The latest version of this story comes from Virginia Commonwealth University, where researcher Emanuele Alves developed a portable, 3D-printed device shaped like an asthma inhaler that uses "Fast Blue" dye and gelatin cartridges to detect delta-9 THC in exhaled breath without requiring secondary lab analysis. The Justice Department provided funding. Marijuana Moment covered it. OregonLive called it "the marijuana breathalyzer police have been waiting for."

But there's more to this image than nostalgia and comedy. What you're looking at in that High Times spread is a snapshot of cannabis before genetics became an industry, before selection pressure from legalization narrowed the gene pool into a parade of similar high-THC cultivars, and before the concept of a "strain" meant something you could trademark and market to dispensary buyers. You're looking at the world cannabis came from. And understanding that world matters a great deal for where cannabis is going.

Reading through hundreds of grower responses, one theme emerges above the specific challenges: growing cannabis well requires learning to manage systems rather than react to crises. The best growers in the thread weren't the ones who had the best solutions to pest outbreaks or overwatering — they were the ones who had built systems stable enough that those crises rarely happened.

The finding: states that legalized medical or recreational marijuana saw significant reductions in non-fatal opioid overdoses. Access to medical cannabis dispensaries was associated with a 15.47 percent reduction in non-fatal opioid overdoses per 100,000 enrollees per quarter. Recreational legalization tracked to an 11.92 percent reduction. Among adults aged 18 to 34, the medical dispensary effect was even sharper — a 23.27 percent reduction.

Eighty-eight percent. Let that sit for a moment. According to the latest nationwide polling from Pew Research Center, released May 26, 2026, only one in ten American adults thinks cannabis should remain fully illegal. That's it. One in ten. The same fraction that still believes the Earth is flat, that cursive handwriting is essential life infrastructure, or that dial-up internet was fast enough.

Based on the findings of a recent preclinical study from the University of California, Riverside (UCR), researchers found that individuals who consumed cannabis for several years usually have a reduced risk of type 2 diabetes and lower body weight. These findings still confused them because of cannabis’s reputation for increasing one’s appetite.

The cannabis community has historically been full of creative people, entrepreneurs, tinkerers, and people who are comfortable thinking outside the frameworks that everyone else takes for granted. That is partly cultural, partly chemical, and largely the result of having spent years operating in spaces where the mainstream rules did not apply. That disposition is an asset right now.

A new study drops, and predictably, the headlines follow. Cannabis triples your lung cancer risk. Heavy users beware. Smoke at your peril. The coverage makes it sound like rolling a joint is roughly equivalent to gargling asbestos, and the average reader is left with one clear takeaway: marijuana will kill you.

There are many ways that the current wave of psychedelic research marks a dramatic breakthrough in society and culture: we no longer see these substances as recreational drugs, but powerful medicines in the realms of mental health, well-being, and neuroscience.

The Wall Street Journal's Future View recently asked college students whether marijuana should be legal. Several of them wrote thoughtful pieces. A few of them wrote arguments that collapse the moment you apply them consistently. I respect the exercise, and I respect that these are young people working through genuinely complex policy questions. But bad arguments don't improve with politeness, so let's get into it.

On May 14, 2026, the U.S. Army published an article titled 'Breaking Down Cannabinoids: How They Compromise Readiness.' The piece, written by two staffers from the Directorate of Prevention, Resilience and Readiness, runs through the standard arguments: cannabinoids impair judgment, Delta-8 can cause false positives, CBD is banned regardless of what your state law says, zero tolerance is the policy, full stop.

Vegan Delta 9 gummies are edible hemp-derived THC products made without animal-based ingredients. Traditional gummies often contain gelatin, which manufacturers usually source from animal collagen. Vegan gummies replace gelatin with plant-based alternatives like pectin, a natural fiber commonly derived from fruits.

The Trump administration had an opening. The hemp market proved the concept. The polling supported the move. The fiscal argument was there. Instead, the White House published a 195-page document that reads like it was written in 1988, invokes psychosis studies with contested methodology, and affirms the recriminalization of a $28 billion industry that was, by any reasonable measure, working.